US regulators approve new type of contraceptive gel

U.S. regulators on Friday approved a birth control gel that works in a new way to prevent pregnancy. Phexxi — pronounced FECK’-see — comes in an applicator that women insert before i...

J&J to stop selling talc-based baby powder in US, Canada

FAIRLESS HILLS, Pa. (AP) — Johnson & Johnson is ending sales of its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, where demand has dwindled amid thousands of lawsuits claiming it...

Pfizer 2Q sales and profit down, but it maintains 2020 views

Drugmaker Pfizer said the COVID-19 pandemic is disrupting its patient testing of experimental drugs and will reduce revenue significantly in the second quarter, but its manufacturing plants are runnin...

Merck cuts 2020 forecasts, sees big pandemic impact in Q2

The pandemic increased sales of Merck medicines during the first quarter as households around the world stocked up, but the drugmaker expects a significant hit this quarter as the full force of the ou...

FDA approves pill for aggressive breast cancer that's spread

U.S. regulators on Friday approved a new drug for an aggressive type of breast cancer that’s spread in the body — including into the brain, where it’s especially tough to treat. The...

Coronavirus scams: guard against fraud cures and other cons

TRENTON, N.J. (AP) — Con artists are finding lots of marks amid the COVID-19 pandemic. Watchdog groups and authorities report a surge of complaints about scams targeting people who fear catching the v...

Malfunctioning EpiPens could harm patients, companies say

U.S. regulators on Tuesday warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions. The Food and Drug Administration issue...

US warns 7 companies over fraudulent coronavirus claims

U.S. regulators warned seven companies to stop selling soaps, sprays and other concoctions with false claims that they can treat the new coronavirus or keep people from catching it. ...

FDA approves drug that lowers cholesterol in a new way

TRENTON, N.J. (AP) — U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pill...

Merck's spins off operations with $6.5B in revenue

Merck is posting a 29% jump in fourth-quarter profit and it's spinning off its women's health division and other operations that churn out $6.5 billion in annual revenues. The drugm...

Pfizer posts Q4 loss, misses Street views, on lower revenue

Drugmaker Pfizer reported a $306 million loss in its fourth quarter after it shifted its consumer health business into a joint venture last year. The company narrowly Wall Street's profit expectations...

US approves fish oil-based drug for cutting heart risks

TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills...

US approves drug to prevent sickle cell pain, organ damage

U.S. regulators on Friday approved a new medicine that can prevent some extremely painful sickle cell disease flare-ups. The Food and Drug Administration approved Novartis AG’s Adakv...

Retailers pull Johnson's baby powder after recall

Walmart, CVS and Rite Aid have pulled some or all 22-ounce bottles of Johnson's baby powder from shelves to avoid confusing consumers, after a minuscule amount of asbestos was found in one bottle. ...

J&J agrees to $117M settlement over pelvic mesh devices

TRENTON, N.J. (AP) — Johnson & Johnson has agreed to a $117 million multistate settlement over allegations it deceptively marketed its pelvic mesh products, which support women's sagging pelvic or...